Shanghai Kindly Entrp Dvlp Grp

KDL Medical released its 2026 interim report, showing first-half net profit attributable to the parent of 112 million yuan, down 10.2% year on year. Operating revenue was 1.09 billion yuan, down 3.2%; non-GAAP net profit attributable to the parent was 110 million yuan, down 10.5%; and net operating cash flow was 116 million yuan, up 57.1%. Second-quarter operating revenue was 552 million yuan, down 4.3%, with net profit attributable to the parent of 58.18 million yuan, down 9.6%. The company said market demand for injection and puncture medical consumables is steadily rising, and the market is expected to expand to 35.61 billion US dollars by 2033.

康德莱 announced that in the first half of 2026, the company achieved operating revenue of 1.089 billion yuan, down 3.21% year on year. Net profit attributable to shareholders of the listed company was 112 million yuan, down 10.23% year on year.